Amgen Selects Veeva Vault CRM for Global Deployment
Sep 16, 2026
Life Sciences
QuVa Pharma Secures National Drug Diversion Software Agreement with Premier
May 5, 2026
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, effective May 1, 2026. The deal enables Premier members to access pre-negotiated pricing and terms for QuVa's BrightStream platform, which supports controlled substance oversight and compliance.
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, announced in a press release. The agreement took effect on May 1, 2026, and allows Premier members to access special pricing and terms negotiated by Premier.
The partnership expands QuVa's relationship with Premier through its BrightStream platform, which uses analytics to help health systems monitor and manage diversion risk. The software provides visibility into controlled substance activity, supports investigations, and generates documentation for regulatory compliance.
According to QuVa, BrightStream also offers reporting, benchmarking, and workflow management tools that unify pharmacy, nursing, and compliance operations. The platform aims to replace manual processes with standardized oversight across hospital systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 29 jaam automation Launches M. for Agentic Work Management Sep 29 Airties and Hitron Unveil SMB Connectivity Platform for ISPs Sep 29 Reactive Technologies Launches Nyquist Grid Technology Licensing Program Sep 28 Pearson and Namibox Plan AI Learning Products for Greater China Sep 28 Bank of America Adds Intelligence Hub to AskGPSMore from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Free newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Systech Launches TraceIQ for Pharmaceutical Supply Chains
Sep 02, 2026
Life Sciences
Ivalua Named a Leader in IDC Direct Spend Assessment
Sep 22, 2026
AI in Supply Chain Management
Quorum Cyber Agrees to Acquire Ontinue
Sep 16, 2026
Acquisitions
CluePoints Releases Three AI Tools for Clinical Data Review
Sep 03, 2026
Healthcare
QC Healthcare Partners With Sanguina for AI Blood Health Screening
Sep 22, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.